Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 4.5 - 9 mm: medical device reports filed with FDA

6,210 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

6,210
device reports naming the brand
0% of all MAUDE reports · about 877 a year
993
reports, 12 months to August 2026
1,031 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

6,210 medical device reports received by FDA name the brand "OsseoSpeed TX 4.5 - 9 mm" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

993 reports arrived in the 12 months to August 2026, close to the 1,031 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (35.9%), loss of osseointegration (32.8%) and osseointegration problem (29.6%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

093185Sep 2021: 41Oct 2021: 38Nov 2021: 71Dec 2021: 502022Jan 2022: 89Feb 2022: 37Mar 2022: 82Apr 2022: 108May 2022: 56Jun 2022: 57Jul 2022: 44Aug 2022: 89Sep 2022: 48Oct 2022: 57Nov 2022: 71Dec 2022: 632023Jan 2023: 71Feb 2023: 57Mar 2023: 57Apr 2023: 44May 2023: 43Jun 2023: 99Jul 2023: 93Aug 2023: 185Sep 2023: 82Oct 2023: 58Nov 2023: 82Dec 2023: 562024Jan 2024: 78Feb 2024: 106Mar 2024: 68Apr 2024: 113May 2024: 73Jun 2024: 86Jul 2024: 96Aug 2024: 133Sep 2024: 101Oct 2024: 100Nov 2024: 65Dec 2024: 632025Jan 2025: 99Feb 2025: 58Mar 2025: 116Apr 2025: 41May 2025: 57Jun 2025: 81Jul 2025: 122Aug 2025: 128Sep 2025: 104Oct 2025: 70Nov 2025: 62Dec 2025: 742026Jan 2026: 107Feb 2026: 43Mar 2026: 84Apr 2026: 84May 2026: 62Jun 2026: 75Jul 2026: 129Aug 2026: 99

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

07781,5552019: 14620192020: 420202021: 1,55520212022: 80120222023: 92720232024: 1,08220242025: 1,01220252026: 6832026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%6,208
Malfunction0%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%6,210
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,22835.9%62.8%
Loss of osseointegration2,03632.8%22.4%
Osseointegration problem1,83829.6%7.7%
Fracturea broken bone1382.2%1.6%
Loosening of implant not related to bone-ingrowth140.2%0.1%
Crackthe device cracked100.2%0%
Malposition of device50.1%0.1%
Off-label use40.1%0%
Device dislodged or dislocated30%0%
Material deformation20%0.1%
Migration or expulsion of device20%0%
Difficult to insertthe device was hard to insert10%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant6,14899%
Inflammationinflammation75112.1%
Osteolysis3515.7%
Pocket erosion3085%
Inadequate osseointegration330.5%
Implant pain80.1%
Sinus perforation50.1%
Painpain, site not specified20%
Swelling/ edema20%
Discomfortdiscomfort10%
Fibrosis10%
Fistula10%
Numbnessnumbness10%
Osteomyelitis10%
Paresthesia10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 4.5 - 9 mmProduct code DZEAll MAUDE reports
Reports6,2103,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 4.5 - 9 mm reports

How many FDA reports name OsseoSpeed TX 4.5 - 9 mm?

6,210 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 993 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (35.9%), loss of osseointegration (32.8%), osseointegration problem (29.6%), fracture (2.2%) and loosening of implant not related to bone-ingrowth (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 4.5 - 9 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.